East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, has announced the firm’s first healthcare-focused fund with the amount of USD 30-million, which is dedicated to supporting innovative healthcare solutions in Indonesia, according to reporting from BioSpectrum Asia Edition.
With a strong commitment to fostering innovation and improving healthcare access in Indonesia, the “East Ventures Healthcare Fund” aims to empower and support promising Indonesian startups that address the unique challenges and opportunities in the Indonesian healthcare landscape.
“Indonesia is one of Southeast Asia’s most dynamic healthcare markets with enormous potential for innovation and growth. With our extensive experience in investing across sectors and stages, we believe this healthcare fund will play a pivotal role in fostering and catalyzing healthcare innovation in Indonesia,” said Willson Cuaca, Co-Founder and Managing Partner at East Ventures.
BioSpectrum Asia Edition, say that Before the creation of this fund, East Ventures has been active in investing in healthcare startups and companies in the region, making the firm has 30-portfolio companies in healthcare vertical today. It includes recent investments such as Mesh Bio, AMILI, Aevice Health, Etana, and Diri Care. Moreover, while investments in genomics-related ventures were relatively novel in 2018, East Ventures has invested in genomics startups, such as NalaGenetics and Nusantics, which is now leading the genomics-based healthcare revolution in Indonesia and Southeast Asia.
Source: BioSpectrum Asia Edition